I saw a posting for a hospital position in my area and was wondering what products this representative would be promoting. I have heard that it is critical care but not sure what products would be.
It's the Ilaris situation all over again. They are going to post, interview, and start hiring just to learn what everyone else knows, the drug won't get approved.
These positions have all been reserved for the current Gen Meds reps. They value our loyalty and will reward us all with this developmental opportunity.
Just keep thinking that sweet cheeks. That is so going to happen in an organization as rep friendly as this company
Nice Spin, but hospital selling is different than Primary Care and I'm not certain IHC reps are even qualified unless your a KAM.
If "they" do this, serelaxin will be a flop even if RELAX II hits ALL endpoints with statistical significance, which is HIGHLY unlikely.
Not completely over. They need to look at FDA letter and see if they can remedy. Much riskier for reps to come on board now, but company is still moving forward in hopes of an eventual launch
What are you smoking? The medical panel voted 11 to 0 not to approve confirming that the existing data dosesn't support use. Without a new trial with different results, the drug is dead, which was also the result of the EMEA review in Europe.
I guess the FDA hearing, the discussion, the vote, and the news coverage are all an early "April fools" joke! I also guess you have lost touch with reality.
When your ready to address your denial, read this: http://www.forbes.com/sites/larryhusten/2014/03/27/fda-advisory-panel-recommends-against-approval-of-novartis-heart-failure-drug/
